Sarah Glass

Dr. Sarah Glass is the Chief Operating Officer at n-Lorem Foundation. Sarah received her Ph.D. in Molecular Genetics at Ohio State University where she trained in rare inherited cancer syndromes. She has over 20 years of experience in clinical development and research across academia, pharmaceutical companies, and CROs. Sarah brings significant strengths and experience as an accomplished research geneticist, rare disease drug developer, and clinical trialist. She is acclaimed for forging key strategic partnerships across rare disease sectors and has driven efficiencies to decrease patient/ caregiver burden in clinical research. Most notably, Sarah combines professional expertise and training with the perspective of a parent. This allows Sarah to not only personally understand the challenges faced by the patients and their families, but also to translate this understanding into n-Lorem’s paradigm-shifting platform solution for the ultra-rare community. Outside of n-Lorem, Sarah volunteers as chair of the DYRK1A Medical and Scientific advisory board and is engaged in many rare disease organizations to ensure collaboration in reaching common goals.